Promotility agents in the intensive care unit.
Zaloga
G P
GP
Marik
P
P
D020117:Cisapride / Q000627:therapeutic use; D004750:Enteral Nutrition / Q000009:adverse effects; D004917:Erythromycin / Q000627:therapeutic use; D005765:Gastrointestinal Agents / Q000627:therapeutic use*; D005769:Gastrointestinal Motility / Q000187:drug effects*; D018589:Gastroparesis / Q000150:complications / Q000188:drug therapy* / Q000209:etiology; D006801:Humans; D007362:Intensive Care Units; D008787:Metoclopramide / Q000627:therapeutic use
D005765:Gastrointestinal Agents; D004917:Erythromycin; D008787:Metoclopramide; D020117:Cisapride